A clinical trial to study the effects of two drugs, Tilakusumadi Lepa and Sarjarasadi Lepa in the treatment of Palmo Plantar Psoriasis

A Comparative Clinical Study On The Effect of Tilakusumadi Lepa and Sarjarasadi Lepa in the Management of Vipadika Palmo Plantar Psoriasis - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070877

Enrollment

Registered

2024-07-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who fulfill the diagnostic criteria i.e. presenting with classical signs and symptoms of Vipadika. 2. Subjects of age between 18-60 year, irrespective of sex, religion, occupation and economic status will be selected.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from hemolytic disorder, bleeding disorders, hereditary problems. 2. Patients suffering from any other major systemic disorders like diabetic mellitus, HIV etc. 3. Associated with other forms of skin diseases. 4. Pregnant women and Lactating mothers.

Design outcomes

Primary

Measure	Time frame
Reduction in Sign and Symptoms of VipadikaTimepoint: 45 days	—

Secondary

Measure	Time frame
1.Cost Effective Treatment 2.To observe adverse effects if any.Timepoint: 45 Days	—

Countries

India

Contacts

Public ContactDr Bandana Dhall

Kunwar Shekhar Vijendra Ayurved Medical College And Research Centre, Shobhit University

tushmaurya25@gmail.com9910570579

Outcome results